HSBC TUR.WAR.OP.END. TRL/ DE000HS52RB5 /
2024-05-03 1:35:59 PM | Chg.+0.6500 | Bid2:19:09 PM | Ask2:19:09 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
2.7000EUR | +31.71% | 2.7000 Bid Size: 9,760 |
3.0200 Ask Size: 9,760 |
DaVita Inc | 122.238 USD | 2078-12-31 | Call |
GlobeNewswire
04-26
Benevity’s 2024 Corporate Goodness Awards Celebrate Groundbreakers in Social Impact
GlobeNewswire
2023-11-17
Outstanding 12-month first-in-human data from Xeltis’ aXess hemodialysis vascular conduit trial pres...
GlobeNewswire
2023-08-15
Elevar Therapeutics Names Dr. Chris Galloway Vice President of Clinical Development
GlobeNewswire
2022-03-21
Chinook Therapeutics Announces Appointment of Dr. Mahesh Krishnan to its Board of Directors
GlobeNewswire
2022-03-07
The Oncology Institute Announces Promotions for Dr. Daniel Virnich and Dr. Matt Miller
GlobeNewswire
2022-02-10
Miromatrix to Ring Nasdaq Closing Bell on National Donor Day, February 14, 2022
GlobeNewswire
2021-10-07
Miromatrix Announces the First Successful Transplant of a Bioengineered Whole Organ in a Large Anima...
GlobeNewswire
2021-10-01
AAON Increases Board Size and Appoints Bruce Ware and David Stewart as Independent Directors
GlobeNewswire
2021-09-09
ACTION BEHAVIOR CENTERS HIRES NEW GENERAL COUNSEL AND CHIEF COMPLIANCE OFFICER
GlobeNewswire
2021-09-09
Miromatrix Welcomes Dr. John Barry as Vice President of Research and Development
GlobeNewswire
2021-08-11
Miromatrix Announces Key Strategic Investors to Advance the Development of Bioengineered Livers and ...
GlobeNewswire
2021-08-05
Vystar Details Preliminary Plans for RxAir Spin Off as Shareholder Dividend